Comparing the Efficacy of Nasal Continuous Positive Airway Pressure and Nasal Intermittent Positive Pressure Ventilation in Early Management of Respiratory Distress Syndrome in Preterm Infants
Comparing the Efficacy of Nasal Continuous Positive Airway Pressure and Nasal Intermittent Positive Pressure Ventilation in Early Management of Respiratory Distress Syndrome in Preterm Infants
نویسندگان: منیژه مصطفی قره باغی , محمدباقر حسینی , قدرت اله عیوضی آتش بیک , ساناز یثربی نیا
کلمات کلیدی: Nasal Continuous
Positive Airway Pressure;
Preterm Infants;
Mechanical Ventilation;
Bronchopulmonary Dysplasia;
Respiratory Distress Syndrome,
Newborn
نشریه: 26055 , 2 , 34 , 2019
| نویسنده ثبت کننده مقاله |
منیژه مصطفی قره باغی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
دانشکده پزشکی |
| کد مقاله |
66175 |
| عنوان فارسی مقاله |
Comparing the Efficacy of Nasal Continuous Positive Airway Pressure and Nasal Intermittent Positive Pressure Ventilation in Early Management of Respiratory Distress Syndrome in Preterm Infants |
| عنوان لاتین مقاله |
Comparing the Efficacy of Nasal Continuous Positive Airway Pressure and Nasal Intermittent Positive Pressure Ventilation in Early Management of Respiratory Distress Syndrome in Preterm Infants |
| ناشر |
4 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح دو – PubMed |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Objectives: There is a tendency to use noninvasive ventilation (NIV) as a substitute for
mechanical ventilation in preterm infants who need respiratory support. Two important
modes of NIV include nasal continuous positive airway pressure (NCPAP) and nasal
intermittent positive pressure ventilation (NIPPV). We sought to compare the efficacy
of NCPAP and NIPPV as early respiratory support in preterm infants with respiratory
distress syndrome in reducing the need for intubation, surfactant administration, and
mechanical ventilation. Methods: We conducted a randomized clinical trial. Sixty-one
preterm infants with a gestational age of 28–32 weeks and a birth weight < 1500 g were
randomly allocated to early NCPAP (n = 31) or NIPPV (n = 30) groups. The primary
outcome was the need for intubation and mechanical ventilation in first 72 hours of
life and the secondary outcome was oxygen dependency beyond day 28 post-birth.
Results: Surfactant replacement therapy was done in 15 neonates (50.0%) in the NIPPV
group and 19 neonates (61.3%) in the NCPAP group, odds ratio (OR) = 1.58 (95%
confidence interval (CI): 0.57–4.37; p = 0.370). Intubation and mechanical ventilation
in the first 72 hours of life were needed in five cases (16.7%) in the NIPPV group and
two cases (6.5%) in the NCPAP group, OR = 2.90 (95% CI: 0.51–16.27; p = 0.250). The
mean duration of hospitalization was 26.2±17.4 days in the NIPPV group and 38.4±19.2
days in the NCPAP group, p = 0.009. Bronchopulmonary dysplasia (BPD) occurred in
two (6.7%) neonates in the NIPPV group and eight (25.8%) neonates in the NCPAP
group, p = 0.080. Conclusions: NIPPV and NCPAP are similarly effective as initial
respiratory support in preterm infants in reducing the need for mechanical ventilation
and occurrence of BPD. The duration of hospitalization was significantly reduced using
NIPPV in our study. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| OS-OMJ-D-18-00080 (06C).pdf | 1398/02/08 | 405983 | دانلود |
| OS-OMJ-D-18-00080 (06C).pdf | 1397/12/21 | 405983 | دانلود |